NGF and Parkinson disease: In particular, this latter has been recently identified as a possible biomarker for PD (Xu et al., 2018), while serum NGF was found to be decreased only in Grade I-II (according to the Hoehn and Yahr scale) PD patients (Pedre et al., 2002).